Auto-generated challenge from hypothesis h-var-adfecef68a (score=0.822). Target: NLRP3, CASP1, IL1B, PYCARD. Question: Can targeting Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates lead to therapeutic benefit in neurodegeneration? Falsifiable prediction: NLRP3 inhibition will reduce neuroinflammation and prevent neuronal loss.